Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

 4,900.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 1,045
  • Market Cap: 255.76m

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

1 Day Chart (29-02-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 3.1% 0.0%
Div Cover 1.1 n/a
Op Mrgn 78.3% 80.0%
ROCE 83.0%  
Latest F'cast
P/E 30.5 30.0
PEG 3.4 7.8
Pr/Revenue 20.0 18.6
Pr/Book 21.2  
Latest F'cast
Revenue 9.4% 9.2%
PBT 9.2% 10.5%
EPS 9.0% 3.8%
DPS 20.6% -100.0%

Bioventix Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 9.29 6.97 114.04p 32.8 8.2 +4% 73.00p 2.0%
30-Jun-20 10.31 8.23 139.41p 29.8 1.4 +22% 88.00p 2.1%
30-Jun-21 10.93 8.12 129.22p 30.7 n/a -7% 105.00p 2.6%
30-Jun-22 11.72 9.28 147.32p 23.4 1.7 +14% 126.00p 3.7%
30-Jun-23 12.82 10.13 160.63p 24.0 2.7 +9% 152.00p 3.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Bioventix Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-24 14.00 11.20 166.80p 29.4 7.7 +4% n/a 0.0%
30-Jun-25 15.10 12.10 180.10p 27.2 3.4 +8% n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Bioventix Company Announcements

Director/PDMR Shareholding 29-Jan-2024 15:15 RNS
Result of AGM 07-Dec-2023 15:26 RNS
Director/PDMR Shareholding 28-Nov-2023 15:26 RNS

Latest Bioventix Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,900.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 5,060.00
52 Week Low 3,500.00
Volume 1,045
Shares Issued 5.22m
Market Cap 255.76m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.92% below the market average98.92% below the market average98.92% below the market average98.92% below the market average98.92% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
91.58% above the market average91.58% above the market average91.58% above the market average91.58% above the market average91.58% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
33.68% below the market average33.68% below the market average33.68% below the market average33.68% below the market average33.68% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
47.29% below the market average47.29% below the market average47.29% below the market average47.29% below the market average47.29% below the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 09-Nov-23 06-Apr-23
Paid 24-Nov-23 21-Apr-23
Amount 90.00p 62.00p

Trades for 29-Feb-2024

Time Volume / Share Price
15:36 44 @ 4,850.00p
15:36 44 @ 4,800.00p
14:30 52 @ 4,869.00p
14:12 1 @ 4,869.00p
13:50 120 @ 4,875.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page